Cited 0 times in
10-year trajectory of beta-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ohn, JH | - |
dc.contributor.author | Kwak, SH | - |
dc.contributor.author | Cho, YM | - |
dc.contributor.author | Lim, S | - |
dc.contributor.author | Jang, HC | - |
dc.contributor.author | Park, KS | - |
dc.contributor.author | Cho, NH | - |
dc.date.accessioned | 2018-05-04T00:23:30Z | - |
dc.date.available | 2018-05-04T00:23:30Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 2213-8587 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/14727 | - |
dc.description.abstract | BACKGROUND: The relative contributions of beta-cell function and insulin sensitivity in the pathogenesis of type 2 diabetes are not fully understood. We investigated the longitudinal change in beta-cell function and insulin sensitivity in the development of diabetes and the role of genetic variants in deterioration of glucose tolerance. METHODS: We followed up 4106 participants with normal glucose tolerance (NGT) from the Korean Genome and Epidemiology Study with oral glucose tolerance tests every 2 years for 10 years. We estimated pancreatic beta-cell function with the 60 min insulinogenic index (IGI60) and insulin sensitivity with the composite (Matsuda) insulin sensitivity index (ISI). We investigated the association of 66 known type 2 diabetes genetic variants with risk of prediabetes or diabetes and impaired beta-cell function and insulin sensitivity. FINDINGS: During 10 years of follow-up, 1093 (27%) of 4106 participants developed prediabetes and 498 (12%) participants developed diabetes. Compared with participants who remained NGT, those who progressed to diabetes had a lower IGI60 (unadjusted data 5.1 muU/mmol [95% CI 0.5-56.1] vs 7.9 muU/mmol [0.5-113.8]: p<0.0001) and lower ISI (unadjusted data 8.2 [2.6-26.0] vs 10.0 [3.2-31.6]: p<0.0001) at baseline. Participants who had NGT at 10 years showed a decrease in ISI (adjusted data 10.1 [9.9-10.3] vs 7.4 [7.3-7.6]: p<0.0001) but a compensatory increase in IGI60 (adjusted data 6.9 muU/mmol [6.5-7.2] vs 11.7 muU/mmol [11.2-12.1]: p<0.0001) compared with baseline. By contrast, participants who developed diabetes showed a decrease in ISI (adjusted data 8.4 [8.0-8.7] vs 3.0 [2.8-3.2]: p<0.0001) but no significant compensatory increase (p=0.95) in IGI60. A genetic variant near the glucokinase gene (rs4607517) was significantly associated with progression to prediabetes or diabetes (hazard ratio 1.27, 1.16-1.38: p=1.70 x 10(-7)). INTERPRETATION: Decreased beta-cell function, which might be determined partly by genetic factors, and impaired beta-cell compensation for progressive decline in insulin sensitivity are crucial factors in the deterioration of glucose tolerance. FUNDING: South Korean Ministry of Health & Welfare. | - |
dc.language.iso | en | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Blood Glucose | - |
dc.subject.MESH | Diabetes Mellitus, Type 2 | - |
dc.subject.MESH | Disease Progression | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Glucose Tolerance Test | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Insulin | - |
dc.subject.MESH | Insulin Resistance | - |
dc.subject.MESH | Insulin-Secreting Cells | - |
dc.subject.MESH | Longitudinal Studies | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Prospective Studies | - |
dc.title | 10-year trajectory of beta-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study | - |
dc.type | Article | - |
dc.identifier.pmid | 26577716 | - |
dc.contributor.affiliatedAuthor | 조, 남한 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1016/S2213-8587(15)00336-8 | - |
dc.citation.title | The lancet. Diabetes & endocrinology | - |
dc.citation.volume | 4 | - |
dc.citation.number | 1 | - |
dc.citation.date | 2016 | - |
dc.citation.startPage | 27 | - |
dc.citation.endPage | 34 | - |
dc.identifier.bibliographicCitation | The lancet. Diabetes & endocrinology, 4(1). : 27-34, 2016 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.identifier.eissn | 2213-8595 | - |
dc.relation.journalid | J022138587 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.